Gregory Sahlem retweeted
Worldwide, someone dies from drug or alcohol addiction every 4 minutes.
Wellcome Leap's $50M Untangling Addiction program seeks breakthroughs that will quantify addiction susceptibility and reduce the risk of relapse.
Learn more: bit.ly/47dn2tO
Gregory Sahlem retweeted
New publication!
We explore resting-state changes associated with the clinical improvements induced by the Stanford Neuromodulation Therapy (SNT) TMS.
Special thanks to @Stanford_BSL
#tms #neuroimaging #psychiatry #depression #neurostimulation #restingstate #stanfordmedicine
Gregory Sahlem retweeted
We are pleased to announce, Colleen Hanlon, PhD, is the recipient of the 2023 International Brain Stimulation Early Career Award, which will be presented at the #BrainStimConf, 18-22 Feb, 2023, in Portugal. Learn more about Colleen Hanlon here. elsevier.com/events/conferen…
Gregory Sahlem retweeted
We expect commercial launch of #SAINT to begin later in '23 on a limited basis. We're building a significant waitlist and engaging with multiple teaching institutions, hospitals, clinics, clinicians, and medical professionals. Join our waitlist here:
ow.ly/rwfr50KEZNT
Gregory Sahlem retweeted
sciencedirect.com/science/ar…
Another paper to come out of our work on long-term effects of behavior therapy for youth with tics/Tourette. We examined the question we so often receive from parents, "What happens to tics as we get older?"
@TouretteAssn @touretteworld
Gregory Sahlem retweeted
Excited to share our new #openaccess paper comparing @Brainsight neuronavigated vs. cap-based #TMS targeting in 11,230 measurements across 42 participants, out now in @brainstimj. 4 take-home points 🧵 1/5
brainstimjrnl.com/article/S1…
Gregory Sahlem retweeted
Yay! Despite my initial skepticism, it turns out that 600 Pulses of iTBS does in fact cause reliable cortical facilitation in a stable Brain state. *** Breaking news: we have already replicated this experiment with similar results!!! *** @CzotyLab_atWF @LindseyGalboMS @pczoty
Probing the effects of multiple sessions of iTBS on cortical excitability in a macaque model brainstimjrnl.com/article/S1…
Gregory Sahlem retweeted
Contract Supports Research into Personalized Treatments for Depression bit.ly/3h5ngKP Check out Dr. Liston's contribution to the 2021 NPP Reviews issue: rdcu.be/cHxG9 @WeillCornell @npp_journal
Gregory Sahlem retweeted
Effects of transcranial magnetic stimulation on the human brain recorded with intracranial electrocorticography: First-in-human study biorxiv.org/content/10.1101/… (thread coming soon)
Gregory Sahlem retweeted
ajp.psychiatryonline.org/doi…
cbsnews.com/news/this-week-o…
We are on CBS Sunday Morning this Sunday. Please RT and spread the word. @APAPubJournals @StanfordPSY @Stanford @StanfordMed
Gregory Sahlem retweeted
The FDA has granted Breakthrough Device Designation for our individualized, #non-invasive, investigational #neuromodulation technology for people with major #depression. More here: ow.ly/Utws50GB4mL
#fMRI #targeted #brainhealth #mentalhealth #targeted
Gregory Sahlem retweeted
Encouraging data in @APAPubJournals from our double-blinded RCT evaluating Stanford Neuromodulation Therapy (SNT) for treatment-resistant #depression. After 5 days, 79% in the active group experienced remission from depression compared to 13% in sham. ajp.psychiatryonline.org/doi…

















